In addition, FDA is proposing two other constraints about the submission of a supplemental PMTA. Below proposed §?1114.fifteen(a), a supplemental PMTA could not be submitted in which the marketing and advertising purchase for the original tobacco product or service has long been withdrawn or has been quickly suspended or is the topic of temporary